TEGRENMERAN EXPRESSED RECEPTOR BINDING DOMAIN (RBD) OF THE SPIKE GLYCOPROTEIN FROM OMICRON VARIANTS BA.4/5 WITH C233S
UNII 97T55W4MRW

Substance Identification & Data

This profile provides standardized clinical and technical data for Tegrenmeran Expressed Receptor Binding Domain (rbd) Of The Spike Glycoprotein From Omicron Variants Ba.4/5 With C233s, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 97T55W4MRW.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
97T55W4MRW
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
TEGRENMERAN EXPRESSED RECEPTOR BINDING DOMAIN (RBD) OF THE SPIKE GLYCOPROTEIN FROM OMICRON VARIANTS BA.4/5 WITH C233S
Official standardized name for this substance within the FDA UNII nomenclature system.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tegrenmeran Expressed Receptor Binding Domain (rbd) Of The Spike Glycoprotein From Omicron Variants Ba.4/5 With C233s. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

TEGRENMERAN EXPRESSED RECEPTOR BINDING DOMAIN (RBD) OF THE SPIKE GLYCOPROTEIN FROM OMICRON VARIANTS BA.4/5 WITH C233S

External Clinical & Regulatory Resources

NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record